The role of lutein in eye-related disease

scientific article published on 22 May 2013

The role of lutein in eye-related disease is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.3390/NU5051823
P932PMC publication ID3708350
P698PubMed publication ID23698168
P5875ResearchGate publication ID236932101

P50authorKakarla V ChalamQ56997192
P2093author name stringWenhua Li
Raluca Rusovici
Keyvan Koushan
Lee R Ferguson
P2860cites workThe influence of supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular pigmentationQ81247711
Comparison of dietary supplementation with lutein diacetate and lutein: a pilot study of the effects on serum and macular pigmentQ83686254
Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyesQ24673347
Location of macular xanthophylls in the most vulnerable regions of photoreceptor outer-segment membranesQ27690643
The Relationship of Dietary Carotenoid and Vitamin A, E, and C Intake With Age-Related Macular Degeneration in a Case-Control StudyQ28248143
Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retinaQ28375737
Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patientsQ30858951
Macular pigment: quantitative analysis on autofluorescence imagesQ31025663
Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye.Q31951685
Raman detection of macular carotenoid pigments in intact human retina.Q32006525
Macular pigment lutein is antiinflammatory in preventing choroidal neovascularizationQ33302396
Quantitative measurement of 3'-oxolutein from human retina by normal-phase high-performance liquid chromatography coupled to atmospheric pressure chemical ionization mass spectrometryQ33433924
rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degenerationQ33508828
Difference in phototoxicity of cyclodextrin complexed fullerene [(gamma-CyD)2/C60] and its aggregated derivatives toward human lens epithelial cellsQ33565924
Lutein protects RGC-5 cells against hypoxia and oxidative stressQ33910891
Dietary supplementation: effects on visual performance and occurrence of AMD and cataractsQ34123345
Is a fluid-mosaic model of biological membranes fully relevant? Studies on lipid organization in model and biological membranes.Q34185827
In vivo snapshot hyperspectral image analysis of age-related macular degenerationQ34202343
Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis StudyQ34305621
The impact of macular pigment augmentation on visual performance using different carotenoid formulations.Q34310338
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study GroupQ34323879
Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthinQ34627818
Antioxidant properties of lutein contribute to the protection against lipopolysaccharide-induced uveitis in mice.Q34633387
Lutein and zeaxanthin supplementation reduces H2O2-induced oxidative damage in human lens epithelial cellsQ34634619
Identification and metabolic transformations of carotenoids in ocular tissues of the Japanese quail Coturnix japonicaQ34650775
Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitaminsQ34719127
Associations between age-related nuclear cataract and lutein and zeaxanthin in the diet and serum in the Carotenoids in the Age-Related Eye Disease Study, an Ancillary Study of the Women's Health InitiativeQ34760523
Chemistry, distribution, and metabolism of tomato carotenoids and their impact on human healthQ34992878
Vertebrate and invertebrate carotenoid-binding proteinsQ35697160
The science behind luteinQ35739866
The relation between serum lipids and lutein and zeaxanthin in the serum and retina: results from cross-sectional, case-control and case study designsQ35847931
The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1)Q36360812
Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutrition Examination SurveyQ36455838
Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans.Q50495142
Toxicity profile of lutein and lutein ester isolated from marigold flowers (Tagetes erecta).Q51713948
Optical density spectra of the macular pigment in vivo and in vitroQ52432348
Lutein and Zeaxanthin in the Eyes, Serum and Diet of Human SubjectsQ57255639
Effects of Lutein Supplementation on Macular Pigment Optical Density and Visual Acuity in Patients with Age-Related Macular DegenerationQ60699438
Macular Pigment Optical Density is Related to Blood Glutathione Levels in Healthy IndividualsQ61976278
Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study GroupQ67803483
Macular pigment in Henle fiber membranes: a model for Haidinger's brushesQ70812207
The macular pigment. II. Spatial distribution in primate retinasQ71356053
Chemistry of singlet oxygen. X. Carotenoid quenching parallels biological protectionQ71472749
Simple determination of retinol, alpha-tocopherol and carotenoids (lutein, all-trans-lycopene, alpha- and beta-carotenes) in human plasma by isocratic liquid chromatographyQ71996490
Lutein and zeaxanthin are associated with photoreceptors in the human retinaQ73154792
Determination of carotenoids in vegetable foods and plasmaQ73269776
Lycopene and beta-carotene decompose more rapidly than lutein and zeaxanthin upon exposure to various pro-oxidants in vitroQ73299685
The reflexion of light from the macular and peripheral fundus oculi in manQ76177204
The occurrence of retinol and carotenoids in human subretinal fluidQ77327934
Solubility, uptake and biocompatibility of lutein and zeaxanthin delivered to cultured human retinal pigment epithelial cells in tween40 micellesQ79566573
Neuroprotective effects of lutein in a rat model of retinal detachmentQ36508346
Phototoxicity and cytotoxicity of fullerol in human lens epithelial cellsQ36606861
Lutein and zeaxanthin intakes and risk of age-related macular degeneration and cataracts: an evaluation using the Food and Drug Administration's evidence-based review system for health claimsQ36648521
Transport and retinal capture of lutein and zeaxanthin with reference to age-related macular degeneration.Q37055765
Macular pigment: new clinical methods of detection and the role of carotenoids in age-related macular degenerationQ37147443
Genotoxic effects of carotenoid breakdown products in human retinal pigment epithelial cellsQ37485773
Dietary wolfberry ameliorates retinal structure abnormalities in db/db mice at the early stage of diabetesQ38294227
Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degenerationQ39575237
Inhibitory effects of lutein on endotoxin-induced uveitis in Lewis ratsQ40275682
Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest populationQ40674461
Application of Lutein and Zeaxanthin in nonproliferative diabetic retinopathyQ42132173
Macular pigment optical density in an ageing Irish population: The Irish Longitudinal Study on Ageing.Q43047847
Protective effects of bilberry ( Vaccinium myrtillus L.) extract against endotoxin-induced uveitis in miceQ43133538
Apolipoprotein E genotype is associated with macular pigment optical densityQ43182517
Macular pigment in donor eyes with and without AMD: a case-control study.Q43514008
Lipofuscin-formation in retinal pigment epithelial cells is reduced by antioxidantsQ43664504
Long-term nutrient intake and early age-related nuclear lens opacitiesQ43670254
Lutein and zeaxanthin for macular degenerationQ43833541
Transformations of selected carotenoids in plasma, liver, and ocular tissues of humans and in nonprimate animal models.Q44198727
Lens aging in relation to nutritional determinants and possible risk factors for age-related cataract.Q44241367
Antioxidant vitamin intake and risk of Alzheimer diseaseQ44311362
Neuroprotective effect of an antioxidant, lutein, during retinal inflammationQ44386863
Aging of cultured retinal pigment epithelial cells: oxidative reactions, lipofuscin formation and blue light damageQ44390194
Simultaneous determination of tocotrienols, tocopherols, retinol, and major carotenoids in human plasma.Q44666365
Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trialQ44696848
Extramitochondrial tricarboxylic acid cycle in retinal rod outer segments.Q44958279
Nutritional manipulation of primate retinas, I: effects of lutein or zeaxanthin supplements on serum and macular pigment in xanthophyll-free rhesus monkeys.Q45028016
Macular pigment density and aging, assessed in the normal elderly and those with cataracts and age-related macular degeneration.Q45110226
Macular pigment and percentage of body fat.Q45124537
Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD.Q45124952
The singlet oxygen and carotenoid interactionQ45187333
Incidence and prevalence of uveitis in Veterans Affairs Medical Centers of the Pacific NorthwestQ45331673
Augmentation of macular pigment following implantation of blue light-filtering intraocular lenses at the time of cataract surgery.Q45921404
Extra-mitochondrial aerobic metabolism in retinal rod outer segments: new perspectives in retinopathies.Q46028160
Plasma carotenoids of monkeys (Macaca fascicularis and Saimiri sciureus) fed a nonpurified dietQ46275165
The utility of using customized heterochromatic flicker photometry (cHFP) to measure macular pigment in patients with age-related macular degenerationQ46381295
Lutein and antioxidants in the prevention of age-related macular degenerationQ46853771
Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotypeQ48110773
Natural tocopherols in a dietary supplement of lutein affect tissue distribution of tocopherols in young rats.Q49112401
P275copyright licenseCreative Commons Attribution 3.0 UnportedQ14947546
P6216copyright statuscopyrightedQ50423863
P433issue5
P407language of work or nameEnglishQ1860
P921main subjecthydrocarbonQ43648
inorganic compoundQ190065
eye diseaseQ3041498
P5008on focus list of Wikimedia projectScienceSourceQ55439927
P304page(s)1823-1839
P577publication date2013-05-22
P1433published inNutrientsQ7070485
P1476titleThe role of lutein in eye-related disease
P478volume5

Reverse relations

cites work (P2860)
Q36134896A pilot comparison of phospolipidated lutein to conventional lutein for effects on plasma lutein concentrations in adult people
Q38636016Absolute and estimated values of macular pigment optical density in young and aged Asian participants with or without age-related macular degeneration.
Q36966858Absorption, metabolism, and functions of β-cryptoxanthin
Q47161141Associations between fruit and vegetable, and antioxidant nutrient intake and age-related macular degeneration by smoking status in elderly Korean men.
Q64069414Asymmetric Spontaneous Intercalation of Lutein into a Phospholipid Bilayer, a Computational Study
Q55002264Bioaccessibility of phenolic compounds, lutein, and bioelements of preparations containing Chlorella vulgaris in artificial digestive juices.
Q36980308Current results on the potential health benefits of lutein
Q47330811Diet and risk of diabetic retinopathy: a systematic review
Q57134980Dietary Consumption of Lutein and Zeaxanthin in Panama: A Cross-Sectional Study
Q35652661Dietary supplement enriched in antioxidants and omega-3 protects from progressive light-induced retinal degeneration
Q37628418Effect of Carotenoid Supplemented Formula on Carotenoid Bioaccumulation in Tissues of Infant Rhesus Macaques: A Pilot Study Focused on Lutein.
Q47116595Evolution, Development and Function of Vertebrate Cone Oil Droplets
Q89477374Fruits
Q89964068Intravitreal Delivery of Melatonin Is Protective Against the Photoreceptor Loss in Mice: A Potential Therapeutic Strategy for Degenerative Retinopathy
Q57177518Intrinsic and Extrinsic Factors Impacting Absorption, Metabolism, and Health Effects of Dietary Carotenoids
Q36297031Measurement of macular pigment optical density among healthy Chinese people and patients with early-stage age-related macular degeneration
Q64260044Mechanism and Potential of Egg Consumption and Egg Bioactive Components on Type-2 Diabetes
Q89125016Mechanisms enhancing the protective functions of macular xanthophylls in the retina during oxidative stress
Q55113695Modulatory Effect of Carotenoid Supplement Constituting Lutein and Zeaxanthin (10:1) on Anti-oxidant Enzymes and Macular Pigments Level in Rats.
Q26741819Molecular Approaches to Genetically Improve the Accumulation of Health-Promoting Secondary Metabolites in Staple Crops-A Case Study: The Lipoxygenase-B1 Genes and Regulation of the Carotenoid Content in Pasta Products
Q92494709Nutrient Deprivation-Associated Changes in Green Microalga Coelastrum sp. TISTR 9501RE Enhanced Potent Antioxidant Carotenoids
Q38317289Nutritional supplements in age-related macular degeneration
Q55607113Oral Photoprotection: Effective Agents and Potential Candidates.
Q46841764Phytochemical profile, antioxidative and anti-inflammatory potentials of Gynura bicolor DC.
Q57035994Poly (D, L-lactide-co-glycolide)-phospholipid nanocarrier for efficient delivery of macular pigment lutein: absorption pharmacokinetics in mice and antiproliferative effect in Hep G2 cells
Q37617691Potential role of carotenoids as antioxidants in human health and disease
Q36941690Protective Effect of Proanthocyanidins from Sea Buckthorn (Hippophae Rhamnoides L.) Seed against Visible Light-Induced Retinal Degeneration in Vivo
Q28071781The Multiple Facets of Lutein: A Call for Further Investigation in the Perinatal Period
Q45879666Therapeutic Approach of Nanotechnology for Oxidative Stress Induced Ocular Neurodegenerative Diseases.
Q28393006Thioredoxin Interacting Protein (TXNIP) and Pathogenesis of Diabetic Retinopathy

Search more.